HUP0104416A3 - Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system and medicaments containing the compounds - Google Patents
Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system and medicaments containing the compoundsInfo
- Publication number
- HUP0104416A3 HUP0104416A3 HU0104416A HUP0104416A HUP0104416A3 HU P0104416 A3 HUP0104416 A3 HU P0104416A3 HU 0104416 A HU0104416 A HU 0104416A HU P0104416 A HUP0104416 A HU P0104416A HU P0104416 A3 HUP0104416 A3 HU P0104416A3
- Authority
- HU
- Hungary
- Prior art keywords
- compounds
- nervous system
- central nervous
- treating diseases
- medicaments containing
- Prior art date
Links
- 210000003169 central nervous system Anatomy 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19854147A DE19854147A1 (de) | 1998-11-24 | 1998-11-24 | Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht |
| PCT/EP1999/008734 WO2000030639A1 (de) | 1998-11-24 | 1999-11-12 | Verwendung von n-substituierten azabicycloalkan-derivaten zur behandlung von erkrankungen des zentralen nervensystems |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0104416A2 HUP0104416A2 (hu) | 2002-04-29 |
| HUP0104416A3 true HUP0104416A3 (en) | 2002-11-28 |
Family
ID=7888824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104416A HUP0104416A3 (en) | 1998-11-24 | 1999-11-12 | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system and medicaments containing the compounds |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1133293A1 (sk) |
| JP (1) | JP2002530333A (sk) |
| KR (1) | KR20010080535A (sk) |
| CN (1) | CN1328455A (sk) |
| AR (1) | AR021502A1 (sk) |
| AU (1) | AU1775300A (sk) |
| BG (1) | BG105549A (sk) |
| BR (1) | BR9915589A (sk) |
| CA (1) | CA2352526A1 (sk) |
| CZ (1) | CZ20011796A3 (sk) |
| DE (1) | DE19854147A1 (sk) |
| HK (1) | HK1040933A1 (sk) |
| HR (1) | HRP20010472A2 (sk) |
| HU (1) | HUP0104416A3 (sk) |
| IL (1) | IL143181A0 (sk) |
| NO (1) | NO20012538L (sk) |
| PL (1) | PL348758A1 (sk) |
| SK (1) | SK7112001A3 (sk) |
| TR (1) | TR200101476T2 (sk) |
| WO (1) | WO2000030639A1 (sk) |
| ZA (1) | ZA200103976B (sk) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0519013A2 (pt) | 2004-12-13 | 2009-11-03 | Lilly Co Eli | composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto |
| GB0812310D0 (en) | 2008-07-03 | 2008-08-13 | Syngenta Ltd | Novel herbicides |
| BR112015016992A8 (pt) * | 2013-01-15 | 2018-01-23 | Novartis Ag | uso de agonistas do receptor alfa 7 nicotínico de acetilcolina |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989004311A1 (en) * | 1987-11-12 | 1989-05-18 | American Home Products Corporation | Polycyclicamines with psychotropic activity |
| DE4427648A1 (de) * | 1994-08-04 | 1996-02-08 | Basf Ag | N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung |
| DE4341403A1 (de) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
| DE4427647A1 (de) * | 1994-08-04 | 1996-02-08 | Basf Ag | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
-
1998
- 1998-11-24 DE DE19854147A patent/DE19854147A1/de not_active Withdrawn
-
1999
- 1999-11-12 CN CN99813559A patent/CN1328455A/zh active Pending
- 1999-11-12 PL PL99348758A patent/PL348758A1/xx not_active Application Discontinuation
- 1999-11-12 TR TR2001/01476T patent/TR200101476T2/xx unknown
- 1999-11-12 KR KR1020017006445A patent/KR20010080535A/ko not_active Application Discontinuation
- 1999-11-12 SK SK711-2001A patent/SK7112001A3/sk unknown
- 1999-11-12 WO PCT/EP1999/008734 patent/WO2000030639A1/de not_active Application Discontinuation
- 1999-11-12 CA CA002352526A patent/CA2352526A1/en not_active Abandoned
- 1999-11-12 HU HU0104416A patent/HUP0104416A3/hu unknown
- 1999-11-12 IL IL14318199A patent/IL143181A0/xx unknown
- 1999-11-12 BR BR9915589-3A patent/BR9915589A/pt not_active IP Right Cessation
- 1999-11-12 CZ CZ20011796A patent/CZ20011796A3/cs unknown
- 1999-11-12 JP JP2000583522A patent/JP2002530333A/ja active Pending
- 1999-11-12 AU AU17753/00A patent/AU1775300A/en not_active Abandoned
- 1999-11-12 EP EP99960974A patent/EP1133293A1/de not_active Withdrawn
- 1999-11-24 AR ARP990105979A patent/AR021502A1/es unknown
-
2001
- 2001-05-16 ZA ZA200103976A patent/ZA200103976B/en unknown
- 2001-05-23 NO NO20012538A patent/NO20012538L/no not_active Application Discontinuation
- 2001-05-30 BG BG105549A patent/BG105549A/xx unknown
- 2001-06-21 HR HR20010472A patent/HRP20010472A2/hr not_active Application Discontinuation
-
2002
- 2002-04-12 HK HK02102768.4A patent/HK1040933A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2352526A1 (en) | 2000-06-02 |
| KR20010080535A (ko) | 2001-08-22 |
| NO20012538D0 (no) | 2001-05-23 |
| HRP20010472A2 (en) | 2003-04-30 |
| JP2002530333A (ja) | 2002-09-17 |
| DE19854147A1 (de) | 2000-05-25 |
| CZ20011796A3 (cs) | 2002-05-15 |
| BR9915589A (pt) | 2001-08-07 |
| SK7112001A3 (en) | 2001-12-03 |
| AU1775300A (en) | 2000-06-13 |
| BG105549A (en) | 2001-12-29 |
| PL348758A1 (en) | 2002-06-03 |
| ZA200103976B (en) | 2002-05-16 |
| TR200101476T2 (tr) | 2001-10-22 |
| HK1040933A1 (zh) | 2002-06-28 |
| IL143181A0 (en) | 2002-04-21 |
| WO2000030639A1 (de) | 2000-06-02 |
| AR021502A1 (es) | 2002-07-24 |
| HUP0104416A2 (hu) | 2002-04-29 |
| EP1133293A1 (de) | 2001-09-19 |
| NO20012538L (no) | 2001-07-04 |
| CN1328455A (zh) | 2001-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL320822A1 (en) | Sulphonamidic compounds as therapeutic agents for treatment of central nervous system, method of obtaining novel sulphonamidic compounds and drugs containing such compounds | |
| HUP0103839A3 (en) | Use of certain drugs for treating nerve root injury | |
| IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
| HUP0102556A3 (en) | Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds | |
| GB2305605B (en) | Pipecolic acid derivatives for the treatment of neurological disorders | |
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| IL125404A0 (en) | 4-amino-pyrimidine derivatives medicaments containing these compounds their use and process for their production | |
| IL116998A0 (en) | Novel indoline compounds processes for their preparation and their use for the treatment of CNS disorders | |
| HUP0102300A3 (en) | Use of diazepin derivatives for preparing medicines for treating diseases influenced by somatostatine receptor, and new compounds | |
| PL311999A1 (en) | Piperazine derivatives, therapeutic agents containing them and method of obtaining such derivatives | |
| IL139591A0 (en) | Combination therapy for treatment of bipolar disorders | |
| IL126592A0 (en) | The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders | |
| HUP9701193A3 (en) | Use of n-(4-aryl-thiazol-2-yl)-sulfonamide derivatives for the preparation of pharmaceutical compositions treating neurological disorders, new derivatives, process for their preparation and pharmaceutical compositions containing them | |
| PL350679A1 (en) | Derivatives of 1-arenosulphonyl-2-arylpyrolydine and piperidine for treating central nervous system disorders | |
| IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
| GB2311940B (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| ZA983602B (en) | Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination | |
| EP0750909A4 (en) | USE OF AMINO-HYDROGENATED CHINAZOLINE COMPOUNDS AND THEIR DERIVATIVES FOR BODYING IN DRUG ADDICTION | |
| PL315666A1 (en) | Heterocyclic compounds of therapeutic properties | |
| IL115073A (en) | Use of 5-substituted pyridine-and hexahydroquinoline-3-carboxylic acid derivatives for the preparation of pharmaceutical compositions for the treatment of disorders of the central nervous system some such novel compounds their preparation and pharmaceutical compositions containing them | |
| HUP0102473A3 (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases | |
| HUP0003219A3 (en) | Phthalazine derivatives, process for producing them and pharmaceutical compositions containing them and use of the compounds for producing pharmaceutical compositions useful for treating erectile dysfunction | |
| HUP0102436A3 (en) | Use of reboxetin for preparation of medicament for nervous disorders | |
| HUP0104701A3 (en) | 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders and medicaments containing the compounds | |
| HUP0104416A3 (en) | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system and medicaments containing the compounds |